$145.87-7.69 (-5.01%)
Nutex Health Inc.
Nutex Health Inc. in the Healthcare sector is trading at $145.87 with a market capitalization of $1.0B. Wall Street consensus targets $246.40 (5 analysts), implying a +68.9% move over the next 12 months. The stock is currently 28% below its 52-week high of $204.00, remaining 10.7% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: RSI 16 is oversold, raising the odds of a near-term bounce. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $216.49M↑ | $151.68M↓ | $267.80M↑ | $243.99M↑ | $211.79M |
| Gross Profit | $91.73M↑ | $46.14M↓ | $154.88M↑ | $124.92M↑ | $118.34M |
| Operating Income | $81.27M↑ | $30.92M↓ | $130.37M↑ | $33.68M↓ | $80.66M |
| Net Income | $46.81M↑ | $11.83M↓ | $55.44M↑ | -$17.70M↓ | $21.22M |
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network o...
Nutex Health Inc. (NASDAQ:NUTX) is one of the best medical care facilities stocks to buy according to analysts. Analysts’ average target implies about 25.4% upside, although the stock carries wider target dispersion than larger facility operators, making the risk-reward profile less straightforward. The freshest investor-relevant development came on June 29, when STAT reported on Nutex’s […]
The United States market has shown a robust performance, climbing 1.6% in the last week and an impressive 28% over the past year, with earnings projected to grow by 17% annually. In this dynamic environment, identifying stocks that are potentially undervalued can be crucial for investors looking to capitalize on growth opportunities, especially when there is notable insider action signaling confidence in these companies' prospects.
For the first half of 2025, total patient visits were 93,842, a 15.5% increase from the first half of 2024. Total revenue increased to $244 million for the three months ended June 30, 2025, as compared to total revenue of $76.1 million for the same period in 2024, an increase of 220%. Gross profit was $124.8 million or 51.1% of total revenue for the three months ended June 30, 2025, as compared to gross profit of $22.6 million or 29.7% of total revenue for the same period of 2024.
Over the last 7 days, the United States market has remained flat, yet it has seen a significant rise of 28% over the past year with earnings expected to grow by 16% annually in the coming years. In this dynamic environment, identifying stocks that are potentially undervalued and exhibit insider buying can be an effective strategy for investors looking to capitalize on growth opportunities within small-cap companies.
Over the last 7 days, the United States market has remained flat, yet it is up 28% over the past year with expectations for earnings to grow by 16% per annum in the coming years. In this dynamic environment, identifying undiscovered gems like Nutex Health can offer unique opportunities for investors seeking to uncover stocks with potential growth that align well with current market conditions.